A Johns Hopkins study found that only 36% of rural Medicare patients with advanced non-small cell lung cancer received molecular testing, which can guide targeted treatment.
Only 36% of Rural Medicare Patients With Advanced Lung Cancer Received Molecular Testing
by | Nov 8, 2026 | Uncategorized | 0 comments
Recent Comments